Document is current
Any future updates will be listed below
-
Authors
Rutkowski, Piotr
- License Information
-
More Information
Article History
Received: 23 November 2020
Accepted: 9 January 2021
First Online: 24 February 2021
Disclosures
: Piotr Rutkowski has received honoraria for lectures and serves on the advisory boards ofNovartis, BMS, MSD, Sanofi, Merck, Pierre Fabre, Pfizer, and Blueprint Medicines outside the scope of the manuscript.
Free to read: This content has been made available to all.
